Medicines Distribution Consents




18 AUGUST 2005 NEW ZEALAND GAZETTE, No. 130

                        3181

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health, under the provisions of section 24 (5) of the Act, and are set out in the Schedule hereto:

Schedule

Product: Aromasin
Active Ingredient: Exemestane 25mg
Dosage Form: Coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturers: Pharmacia Italia SpA, Zona Industriale 1, Marino del Tronto, Ascoli Piceno, Italy
Pharmacia Italia SpA, Nerviano, Milan, Italy

Product: Invanz
Active Ingredient: Ertapenem sodium 209.2mg/mL equivalent to 200mg/mL ertapenem free acid
Dosage Form: Powder for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Laboratoires Merck Sharp & Dohme - Chibret, (Mirabel Plant), Clermont-Ferrand, France

Dated this 12th day of August 2005.

GRAEME GILLESPIE, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5387

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product: Colgate Simply White Toothpaste - Sparkling Mint
Active Ingredient: Sodium fluoride 0.22%w/w equivalent to fluoride ion 1000ppm
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer: Colgate-Palmolive Company, Jefferson, Indiana, United States of America

Product: Colgate Simply White Toothpaste - Spearmint
Active Ingredient: Sodium fluoride 0.22%w/w equivalent to fluoride ion 1000ppm
Dosage Form: Toothpaste
New Zealand Sponsor: Colgate-Palmolive Limited
Manufacturer: Colgate-Palmolive Company, Jefferson, Indiana, United States of America

Dated this 12th day of August 2005.

GRAEME GILLESPIE, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5386

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Boostrix-IPV
Active Ingredients: Diphtheria toxoid, adsorbed 2.5Lf U/dose
Pertactin 2.5µg/dose
Pertussis filamentous haemagglutinin 8µg/dose
Pertussis toxoid, adsorbed 8µg/dose
Polio virus type 1 40DAgU/dose
Polio virus type 2 8DAgU/dose
Polio virus type 3 32DAgU/dose
Tetanus toxoid 5Lf U/dose
Dosage Form: Suspension for injection
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Biologicals SA, Rixensart, Belgium



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 130


Gazette.govt.nz PDF NZ Gazette 2005, No 130





✨ LLM interpretation of page content

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
12 August 2005
Medicines Act 1981, Aromasin, Invanz, Pfizer, Merck Sharp & Dohme
  • GRAEME GILLESPIE, Acting Deputy Director-General, Public Health

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
12 August 2005
Medicines Act 1981, Colgate Simply White Toothpaste, Colgate-Palmolive
  • GRAEME GILLESPIE, Acting Deputy Director-General, Public Health

🏥 Consent to the Distribution of New Medicines

🏥 Health & Social Welfare
12 August 2005
Medicines Act 1981, Boostrix-IPV, GlaxoSmithKline
  • GRAEME GILLESPIE, Acting Deputy Director-General, Public Health